Go Pro

Caris Life Sciences (CAI) Earnings Date, Estimates & Call Transcripts

Caris Life Sciences logo
$26.27 +1.69 (+6.88%)
As of 08/21/2026 04:00 PM Eastern

Caris Life Sciences Earnings Summary

Caris Life Sciences posted Q4 2025 earnings on February 26, 2026, reporting an EPS of $0.28, which topped the consensus estimate of $0.01 by $0.27. Quarterly revenue rose 125.4% year-over-year to $292.89 million, above analysts' expectations of $281 million. With a trailing EPS of $0.36 and a P/E Ratio of 72.97, Caris Life Sciences' earnings are expected to grow 223.08% next year, from $0.13 to $0.42 per share.

Consensus EPS
(Feb. 26)
$0.01
Actual EPS
(Feb. 26)
$0.28 Beat By $0.27
Actual Revenue
(Feb. 26)
$292.89M

Q4 2025 Earnings Resources

Get Caris Life Sciences Earnings Alerts

Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Caris Life Sciences and other key companies, straight to your inbox.

Sign Up
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

Caris Life Sciences Analyst EPS Estimates

Current Year EPS Consensus Estimate
$0.13 EPS
Next Year EPS Consensus Estimate
$0.42 EPS

Caris Life Sciences Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails
2/26/2026Q4 2025$0.01$0.28+$0.27$0.28$281.00M$292.89M

Caris Life Sciences Earnings - Frequently Asked Questions

Caris Life Sciences (NASDAQ:CAI) last announced its quarterly earning data on Thursday, February 26, 2026. Learn more on CAI's earnings history.

Caris Life Sciences updated its FY 2026 earnings guidance on Wednesday, August, 5th. The company issued revenue guidance of $1.0 billion-$1.0 billion, compared to the consensus revenue estimate of $1.0 billion.

In the previous quarter, Caris Life Sciences (NASDAQ:CAI) reported $0.28 earnings per share (EPS) to beat the analysts' consensus estimate of $0.01 by $0.27. Learn more on analysts' earnings estimate vs. CAI's actual earnings.

The conference call for Caris Life Sciences' latest earnings report can be listened to online.
Listen to Conference Call

The conference call transcript for Caris Life Sciences' latest earnings report can be read online.
Read Transcript

Caris Life Sciences (NASDAQ:CAI) has a recorded annual revenue of $348.89 million.

Caris Life Sciences (NASDAQ:CAI) has a recorded net income of -$68.09 million. CAI has generated $0.36 earnings per share over the last four quarters.

Caris Life Sciences (NASDAQ:CAI) has a trailing price-to-earnings ratio of 72.97 and a forward price-to-earnings ratio of 202.08.

Caris Life Sciences' earnings are expected to grow from $0.13 per share to $0.42 per share in the next year, which is a 223.08% increase.


Earnings data for NASDAQ:CAI is sourced from Fiscal.ai, with the most recent quarter reported on 2/26/2026. New results are added as companies report their earnings.
From Our Partners